首页> 美国卫生研究院文献>Assay and Drug Development Technologies >Application of G Protein-Coupled Receptor-Heteromer Identification Technology to Monitor β-Arrestin Recruitment to G Protein-Coupled Receptor Heteromers
【2h】

Application of G Protein-Coupled Receptor-Heteromer Identification Technology to Monitor β-Arrestin Recruitment to G Protein-Coupled Receptor Heteromers

机译:G蛋白偶联受体-异构体鉴定技术在监测G蛋白偶联受体-异构体β-arrestin募集中的应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Understanding the role of G protein-coupled receptor (GPCR; also known as a 7 transmembrane receptor) heteromerization in the physiology and pathophysiology of cellular function has now become a major research focus. However, there is currently a lack of cell-based assays capable of profiling the specific functional consequences of heteromerization in a ligand-dependent manner. Understanding the pharmacology specifically associated with heteromer function in contrast to monomer or homomer function enables the so-called biochemical fingerprints of the receptor heteromer to be ascertained. This is the first step in establishing the physiological relevance of heteromerization, the goal of everyone in the field, as these fingerprints can then be utilized in future endeavors to elucidate heteromer function in native tissues. The simple, robust, ligand-dependent methodology described in this study utilizes a novel configuration of components of a proximity-based reporter system. This is exemplified by the use of bioluminescence resonance energy transfer due to the advantages of real-time live cell monitoring of proximity specifically between the heteromer complex and a protein that is recruited in a ligand-dependent manner, in this case, β-arrestin 2. Further, the demonstration of Z′-factor values in excess of 0.6 shows the potential of the method for screening compounds for heteromer-selective or biased activity. Three previously characterized GPCR heteromers, the chemokine receptor heteromers CCR2-CCR5 and CCR2-CXCR4, as well as the angiotensin II receptor type 1-bradykinin receptor type 2 heteromer, have been used to illustrate the profiling capability and specificity of the GPCR heteromer identification technology.
机译:了解G蛋白偶联受体(GPCR;也称为7跨膜受体)异源化在细胞功能生理学和病理生理学中的作用现已成为主要研究重点。然而,目前缺乏能够以配体依赖性方式分析异源化的特定功能后果的基于细胞的测定法。与单体或同聚物功能相反,了解与异聚物功能具体相关的药理学使得能够确定受体异聚物的所谓生化指纹。这是建立异源化的生理相关性的第一步,这是本领域每个人的目标,因为这些指纹可用于将来的工作中,以阐明天然组织中的异源功能。本研究中描述的简单,可靠,依赖配体的方法论利用了基于邻近度的报道分子系统组件的新颖构型。由于利用实时生物活细胞监测异源复合物与以配体依赖性方式募集的蛋白质(在这种情况下为β-arrestin2)之间的邻近性的优势,可以通过生物发光共振能量转移来举例说明此外,Z'-因子值超过0.6的证明表明,该方法可用于筛选化合物的异聚体选择性或偏活性。三种先前表征的GPCR异聚体,趋化因子受体异聚体CCR2-CCR5和CCR2-CXCR4以及血管紧张素II受体1-缓激肽受体2型异聚体已用于说明GPCR异源鉴定技术的谱分析能力和特异性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号